Artixio

Global Regulatory Affairs Services For Life Sciences

End-to-end Regulatory Affairs right from Strategy, Registration, Operations to Post Market Lifecycle Maintenance.

Why Artixio For Your Regulatory Affairs Solutions?

Right from development to registration and post approval support, Artixio provides comprehensive, integrated, regulatory and market intelligence driven services across strategy, writing, dossier preparation, publishing, labelling, artwork, ad-promo and regulatory information management.

Product Development → Approval → Commercialization

Pre-Registration

Registration

Post-Registration

Enabling Access to Innovation Globally

At Artixio, we make it easier for life sciences innovations to reach global markets. By combining regional regulatory knowledge with market insights, we simplify complex processes—helping companies bring their products to patients and end users faster and with confidence.

Ensuring Compliance

Our centralized view of global regulations and strategies to approach diverse, complex markets enable us to ensure compliance of multiple products across multiple markets on ongoing basis.

Commitment to Excellence

With proven experience from successful approvals and key learnings from different markets across product and therapeutic categories, Artixio is committed to excellence by implementing best management and regulatory practices geared towards efficient, reliable solutions for our customers’ regulatory needs.

Regulatory Services

Regulatory Intelligence & Strategy
Medical & Technical Writing
Gap Analysis
Dossier Preparation
Publishing & Submission
Product Registration
New Drug Application (NDA) / Marketing Authorization Applications (MAA)
Investigation New Drug Application (IND) / Clinical Trial Application (CTA)
Marketing Authorization Holder
Post Approval Lifecycle Maintenance
Artwork and Label Review
Ad Promo Review
Distributor and Import Assistance

What Sets Us Apart ?

FAQs

What are key components of global Regulatory Affairs?

Global Regulatory Affairs encompass a variety of activities, including regulatory intelligence and strategy, regulatory and technical writing, dossier gap analysis and preparation, GMP application, publishing and submission to health authorities, artwork and label review, ad promo review, product lifecycle management, health authority liaison and response to queries, legal representation / license holding, regulatory information management and other operational activities to ensure product compliance across multiple markets and therapeutic area / applications.

Artixio’s regulatory intelligence platform is regularly updated with regulations from global heatlh authorities including any new changes in regulations. Coupled with Artixio’s regulatory experts based in 120+ countries and experience in successfully registering and maintaining compliance for complex products, centralized global project management best practices, Artixio supports Regulatory Affaris across multiple countries.

Our regulatory experts are based locally in key markets globally with 15-35 years of experience in successfully registering and managing lifecycle for complex products across pharmaceuticals, biologics, devices and consumer products. Our clients not only benefit from regional insights but appointed Local Legal Representation (LLR) to manage health authority submissions and relations.

Few challenges that companies face while managing global regulatory affairs include, but not limited to, lack of knowledge of local regulations, lack of experience, regional language and cultural nuances, lack of trusted expert with global perspective, irregular processes, inconsistency in documents, intellectual property security, quality of documentation, transparency, maintaining compliance with changing regulations, products portfolio revenue versus cost of compliance/ ROI and others.

Artixio addresses these challenges by providing flexible, budget friendly and timely compliance solutions and regulatory affairs services using global standards for seamless projects delivery, secure information exchange, high quality services, regional expertise and network and systems driven processes.

Artixio has internal regulatory intelligence platform, Dvarka, that tracks global regulatory changes. The platform hosts,

  • Current regulations, directives, regulatory insights
  • Track changes in regulations, new guidelines, notifications from health authorities worldwide
  • Insights by our Regional Regulatory Experts from their experience, attendance to Conference, Seminars, Trade Shows, HA Organized Trainings and Events
  • Artixio’s expert opinions and Case Studies

Still Have Questions ?

Get expert answers tailored to your needs.

Specialized Regulatory Affairs
Services Across Multiple Industries

Pharmaceuticals

MedTech

Cosmetics

Nutrition

Biologics

Veterinary

Expert Regulatory Services To Streamline Compliance

Regulatory Intelligence & Strategy
Medical & Technical Writing
Publishing & Submission
Product Registration
Investigation New Drug Application (IND)
New Drug Application (NDA)
Post Approval Lifecycle Maintenance
Artwork and Label Review
Ad Promo Review

Regulatory Affairs Across Multiple Countries

India

Singapore

Mexico

Brazil

Vietnam

Malaysia

Argentina

Colombia

Taiwan

China

European

Thailand

Indonesia

Philippines

USA

Japan

Qatar

South Korea

Insights from Artixio - Tips & Articles

Pharma Manufacturing Booms in Hidalgo, Mexico

Pharma Manufacturing Booms in

Hildalgo had good pharmaceutical infrastructure and supply chain capabilities, but with no foreign investment...

May 2, 2025
UK Releases Amendment & Guidance on Regulations in 2024 for Medical Devices (Post-market Surveillance Requirements)

UK Releases Amendment &

In January 2025, MHRA UK released guidance on implementation of amendments to Medical Devices...

April 23, 2025
Artixio Announces Grant for Early Stage Medtech Innovators as Part of MedTech InnovateIO Initiative

Artixio Announces Grant for

HYDERABAD, India - March 27, 2024 - Artixio, a leading compliance and commercial consulting...

April 16, 2025